Digital Health Venture Partners (DHVP) Research
Investment Thesis
DHVP describes itself as a value-add, seed-stage venture capital firm that partners early with resilient, mission-driven teams tackling the hardest problems in healthcare. Its thesis is that healthcare was built on closed data and obsolete systems, that policy is now forcing openness, and that AI is turning complexity into clarity. DHVP sees that convergence as a generational opportunity for founders and aims to work where data, AI, and policy collide. The firm takes a thematic approach and invests in durable healthcare solutions across software (AI and SaaS), AI-enabled services, and consumerism.
Core Areas of Investment
The website names three themes:
- Unlocking healthcare data: turning fragmented, inaccessible data into actionable insight across the healthcare system.
- Operationalizing AI to streamline workflows: automating back-office and operational work to cut administrative burden, improve accuracy, and enable more effective care delivery.
- Activating policy tailwinds: building on regulatory and policy shifts that open new business models, including data accessibility, value-based care infrastructure, and new payment and reimbursement models.
The portfolio reflects this: revenue-cycle and payment integrity (Anuly, Claim Health, Cybexys, Brellium), home health and hospice operations (ArcHouse, GeoH, Roger Healthcare), clinical workflow and intelligence (Avo, Cascala), patient access and care navigation (Neon Health, Twig Health, Rovi, Medmo), and consumer-facing care (BeHuman Health, Big Leap Health, Movn Health).
Stage Focus
DHVP is consistently described (LinkedIn, Crunchbase, Caplight) as seed-stage. Caplight also records a Series A (Handl Health, February 2026) where DHVP participated as a co-investor, so follow-on and occasional later-stage participation is plausible. No check size is published, so none is claimed here.
Check Size and Fund
No check size range is stated on the website. SEC Form D filings show DHVP II, L.P. as a pooled investment fund, with one filing showing a $50.0M offering (retrieved July 2026) and another showing an indefinite offering. Arvin Grover is listed as an executive officer. The firm says it is backed by healthcare founders, executives, private equity investors, and family offices, and that most LPs have healthcare ties that can help portfolio companies.
Lead Tendency
Caplight lists DHVP as a co-investor on every recorded 2026 deal (Handl Health, RxUtility, beHuman, Claimeye, Claim Health). That is a small sample and Caplight's lead flag may be incomplete, so lead tendency is recorded as unknown.
Recent Activity
Caplight records five investments between January and February 2026: Claim Health (seed), Claimeye (seed), beHuman (seed), RxUtility (seed), and Handl Health (Series A). The portfolio page also shows newer logos (Anuly, Interactly, Peppermint, Rovi Health, Brellium, Claim Health) added in mid-2026, and Arvin Grover's LinkedIn lists an investor role at Peppermint from May 2026. The Form D filings from July to August 2026 indicate the firm is actively raising or deploying DHVP II. Fund status is treated as actively deploying.
Portfolio Highlights
The portfolio page lists 21 companies, none marked as exited by the page text. The firm claims that over 60% of portfolio companies have signed commercial contracts with customers DHVP proactively introduced through its network, and that 30% have closed two or more contracts. Customer introductions are therefore a central part of the value-add pitch.
Team
- Arvin Grover: Founder and General Partner (Washington, DC area; has been at DHVP since December 2023 per LinkedIn)
- Steve Yaskin: Partner
- Eric Hargan: Advisor (former policymaker)
The firm describes its team as investors, operators, and former policymakers. LinkedIn lists the firm at 2 to 10 employees. Contact is via [email protected] or the contact form, which routes by sender type: company seeking funding, LP, strategic or healthcare operator, VC or PE firm, professional services firm, applicant, or other.
Decision Process
Not published. With a small partnership led by a founder and general partner, decisions are most likely made by the partnership. This is recorded as partnership with low confidence.
Founder Preferences
DHVP says it wants resilient, mission-driven founders working on hard healthcare problems, particularly where data access, AI, and policy shifts create a new business model. Founders who can use DHVP's customer introductions (payers, providers, benefits consultants, health systems) are the natural fit.
Geographic Focus
DHVP is based in Washington, DC. No geographic restriction is stated. Portfolio companies are US healthcare businesses, so the focus is recorded as the US.